Simonović Babić J, Bojović K, Fabri M, Cvejić T, Svorcan P, Nožić D, et al. Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ /ritonavir + dasabuvir + ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia. Vojnosanit Pregl [Internet]. 2021 Feb. 11 [cited 2026 Jul. 12];76(5). Available from: https://asistent.ceon.rs/index.php/vsp/article/view/14677